Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Pol J Vet Sci ; 26(3): 393-399, 2023 09 20.
Article in English | MEDLINE | ID: mdl-37727100

ABSTRACT

Immunoaffinity chromatography (IAC) is a fundamental isolation and purification tool which is incorporated in a substantial range of therapeutic and diagnostic applications. This study has reappraised the usefulness of immunoaffinity chromatography for the purification of polyclonal antibodies. Protein A based IAC is a convenient and reliable method for purification of IgG, from hyperimmunesera (HIS) raised in experimental animals such as rabbits, guinea pigs and mice to be utilized in pharmaceutics and diagnostics. The 146S fraction of Foot and Mouth Disease virus (FMDV) TCID50=10 5.6 was cultured on a baby hamster kidney cell line 21 (BHK-21), concentrated using salt precipitation method using PEG 6000, purified by size exclusion chromatography (SEC) using Sepharose-30 at 254nm absorbance. Purification of 146S FMDV was analyzed using 12% SDS-PAGE which provided two bands of light and heavy chains. The alum-based vaccine, consisting of ≥10µg of 146S FMDV, was applied in 10 male rabbits and 10 male guinea pigs and two animals of each group were taken as a negative control. The titer of serum was calculated using virus neutralization test. A Protein-A kit (Thermo scientific- 44667, 0528.2) was used to purify HIS raised against 146S FMDV and validated using 12% SDS PAGE in reducing condition. The data demonstrate that protein-A affinity chromatography is an efficient tool for the purification of antibodies from hyper-immune sera raised against 146S FMDV and can be used for the production of diagnostic kits e.g. Enzyme linked immuno-sorbent assay (ELISA) and radioimmunoassay.


Subject(s)
Foot-and-Mouth Disease Virus , Male , Cricetinae , Animals , Guinea Pigs , Mice , Rabbits , Immune Sera , Cell Line , Chromatography, Affinity/veterinary , Immunoglobulin G
2.
Iran J Vet Res ; 24(4): 339-344, 2023.
Article in English | MEDLINE | ID: mdl-38799291

ABSTRACT

Background: During past few years, the Ind-2001 lineage of the Middle East-South Asia topotype (ME-SA) of the foot-and-mouth disease (FMD) virus has been implicated in FMD outbreaks in Pakistan. Aims: This work conducts a comprehensive evolutionary analysis of the Ind-2001 and Pan Asia II lineages, with a specific emphasis on their geographical distribution, lineage classification, and sub-lineage distribution within the region. Furthermore, it aims to expand our understanding of the conserved region of the VP1 protein. Methods: Total samples (n=50) were subjected to antigen detection ELISA and RT-PCR for serotype determination. Confirmed serotype-O isolates (n=17) underwent sequencing for lineage comparison, mutation impact assessment on the VP1 protein GH loop, 3D structure prediction, and further comparative analysis. Results: Isolates collected from 2017 to 2020 were identified as serotypes O/ME-SA/Pan Asia II ANT10 and O/ME-SA/Pak14. Notably, isolates collected from 2020 to 2022 belonged to a novel FMDV serotype O/ME-SA/Ind-2001e lineage. Phylogenetic analyses indicated that these strains were distinct from dominant contemporaneous strains which may challenge Pakistan's FMD control measures. These isolates exhibited variance in the VP1 epitope, specifically in amino acid residues 135-155, known to influence neutralizing antibody generation. Conclusion: Observed mutations suggest potential challenges to current vaccination efficacy against FMD. This emphasizes enhanced FMD surveillance and demonstrates that tracking the emergence of the O/ME-SA/Ind-2001e lineage is important for determining FMD control strategies in Asia.

4.
Iran J Vet Res ; 17(4): 231-236, 2016.
Article in English | MEDLINE | ID: mdl-28224005

ABSTRACT

Current research highlights the Hspb1 based screening of eight cat populations of the world to investigate the association of newly found locus within cat mammary tumors. Total 180 cats were screened on the basis of Hspb1 4 bp deletion locus (1514-1517del4) which was observed in six mammary tumor cases in Siamese cat breed. Case-control association study revealed the non-significance with P=0.201 and an overall mutant allele frequency of 0.30 ranging from 0.20-0.40 was observed in other cat populations. Similarly, HWE was also obeyed in combined population samples with P=0.860 and found non-significant with range of 0.429-0.708 in other non-Pakistani cat populations as well. These results might be helpful to understand the association of this novel locus in a better way with large sample size of cases and may also serve as a potential marker for mammary tumor diagnosis, particularly in cats and generally in all other animal populations in comparative genetics and genomics context.

5.
Antiviral Res ; 38(1): 43-53, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9614003

ABSTRACT

Existing murine models for cutaneous herpes simplex virus type 1 (HSV-1) infection have limited relevance to recurrent disease in humans, since the infection is usually primary rather than reactivated and infection occurs in the absence of an established immune response. To obtain a reproducible model to study the effects of topical antiviral therapy on recurrent disease we have adapted a mouse model which employs zosteriform spread of HSV-1 in the presence of adoptive transfer of immunity (ATI) which mimics human recrudescent lesions. Mice were infected with HSV-1 by scarification at the lateroventral line of the neck; 2 days later, the mice received adoptive transfer of immune cells from the cervical lymph nodes of syngeneic mice that had been infected in the ear pinna with the same strain of virus 7 days earlier. ATI resulted in a heightened inflammatory response in the target tissues for virus replication. Virus was cleared more quickly from the infected tissues in comparison with mice similarly inoculated without ATI, however, the intensity and duration of the inflammation was greater. The model was then used to test the effect of a topical formulation of foscarnet. The results presented demonstrate that the ATI model can provide useful data concerning the efficacy of topical antiviral chemotherapy in man.


Subject(s)
Adoptive Transfer , Herpes Simplex , Administration, Topical , Animals , Antiviral Agents/administration & dosage , Antiviral Agents/therapeutic use , Cell Line , Cricetinae , Disease Models, Animal , Ear , Female , Foscarnet/administration & dosage , Foscarnet/therapeutic use , Herpes Simplex/drug therapy , Herpes Simplex/pathology , Herpes Simplex/physiopathology , Humans , Mice , Mice, Inbred BALB C , Recurrence
6.
Antivir Chem Chemother ; 9(1): 19-24, 1998 Jan.
Article in English | MEDLINE | ID: mdl-9875373

ABSTRACT

Recently we have reported a zosteriform murine infection model which employs the adoptive transfer of immune cells (ATI) to recipient infected mice to produce a disease that mimics human recurrent herpes simplex virus (HSV) disease. Mice were infected with HSV-1 by scarification at the lateroventral line of the neck; 2 days later, the mice received immune cells from HSV-1-infected syngeneic mice. Although virus was cleared more quickly from the target tissues of virus replication in recipient mice, ATI resulted in a heightened inflammatory response and delayed healing. This model was used to test the effects of topical formulations containing foscarnet and/or the anti-inflammatory agent, hydrocortisone. Virus clearance and clinical signs, including ear thickness and zosteriform spread of lesions, were studied. Treatment with 3% foscarnet accelerated virus clearance but had little effect on clinical parameters. By contrast, 0.5% hydrocortisone increased the titre and extended the presence of infectious virus for at least 6 days, although the reduction in clinical signs was greater than that obtained with topical foscarnet. Foscarnet in combination with hydrocortisone produced a marked reduction in clinical signs while virus replication was reduced. These results are discussed in relation to the inflammation and discomfort experienced by patients and a possible role for anti-inflammatory formulations in the treatment of HSV reactivation episodes in man.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antiviral Agents/pharmacology , Foscarnet/pharmacology , Herpes Simplex/drug therapy , Hydrocortisone/pharmacology , Administration, Topical , Adoptive Transfer , Animals , Anti-Inflammatory Agents/administration & dosage , Antiviral Agents/administration & dosage , Disease Models, Animal , Drug Combinations , Female , Foscarnet/administration & dosage , Herpes Simplex/immunology , Humans , Hydrocortisone/administration & dosage , Mice , Mice, Inbred BALB C
7.
Res Vet Sci ; 59(2): 139-45, 1995 Sep.
Article in English | MEDLINE | ID: mdl-8525103

ABSTRACT

The most important consequence of equine herpesvirus-1 (EHV-1) infection is abortion. The object of the present study was to characteristic further a murine EHV-1 abortion model and to make comparisons with the natural host with particular reference to the stage of gestation during which the infection occurs. BALB/c mice at different stages of pregnancy were infected intranasally with EHV-1 (strain AB4); they suffered respiratory distress, weight loss, and other constitutional signs of infection. When the virus was inoculated in the late second or early third week of gestation dead or dying fetuses were aborted, whereas infection between seven and nine days of pregnancy led to fetal death and resorption. During the process of resorption, complications were observed. Virus was frequently isolated from the placentas and occasionally from the tissues of the aborting fetuses, depending on the severity of the infection of the placentas. In some cases, therefore, the inoculation resulted in abortion although the infection was restricted to the placenta. Virus antigen was detected in the placentas, lungs and occasionally in other tissues of the aborting fetuses. The potential of this murine model for testing methods for the diagnosis and control of equine abortion is discussed.


Subject(s)
Abortion, Veterinary/virology , Herpesviridae Infections/pathology , Herpesvirus 1, Equid , Animals , DNA, Viral/analysis , Female , Fetus/pathology , Fetus/virology , Gestational Age , Herpesviridae Infections/embryology , Herpesvirus 1, Equid/isolation & purification , Horses , In Situ Hybridization , Mice , Mice, Inbred BALB C , Placenta/pathology , Placenta/virology , Pregnancy
8.
Antimicrob Agents Chemother ; 37(11): 2478-82, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8285638

ABSTRACT

(S)-9-(3-Hydroxy-2-phosphonylmethoxypropyl)adenine (HPMPA) and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) were tested in a mouse model for equine herpesvirus 1-induced abortion. HPMPA, given twice daily, reduced virus replication, but the compound was embryotoxic. A single dose of HPMPC, however, reduced the incidence of abortion and transfer of virus to the fetuses while producing no obvious toxic effects.


Subject(s)
Abortion, Spontaneous/microbiology , Adenine/analogs & derivatives , Antiviral Agents/chemical synthesis , Cytosine/analogs & derivatives , Herpesviridae Infections/prevention & control , Herpesvirus 1, Equid , Organophosphonates , Organophosphorus Compounds/therapeutic use , Adenine/therapeutic use , Adenine/toxicity , Animals , Antiviral Agents/pharmacology , Cidofovir , Cytosine/therapeutic use , Cytosine/toxicity , Female , Herpesviridae Infections/microbiology , Mice , Mice, Inbred BALB C , Organophosphorus Compounds/toxicity , Pregnancy , Virus Replication/drug effects
9.
Antiviral Res ; 18(1): 77-89, 1992 May.
Article in English | MEDLINE | ID: mdl-1329646

ABSTRACT

Equine herpesvirus type 1 (EHV-1) was sensitive to the nucleoside analogue penciclovir (PCV) when tested in tissue culture; the ED50 was 1.6 micrograms/ml. Drug-resistant mutants were selected which were found to be TK-defective and approx. 45-fold less sensitive to PCV compared with the parental strain. PCV was compared with the phosphonyl derivative, HPMPA in mice infected with EHV-1. Both drugs were shown to be effective in vivo, limiting wild-type virus replication in respiratory tissues, and reducing viraemia. The treated mice also showed less clinical signs and reduced histopathology compared with placebo-treated controls. The establishment of latent EHV-1 in the mice, however, was not prevented. The results obtained with mice suggest that antiviral chemotherapy may be practical in the horse and that this possibility is worthy of further investigation in the natural host.


Subject(s)
Acyclovir/analogs & derivatives , Antiviral Agents/pharmacology , Herpesviridae Infections/drug therapy , Herpesvirus 1, Equid/drug effects , Organophosphonates , Acyclovir/pharmacology , Acyclovir/therapeutic use , Adenine/analogs & derivatives , Adenine/pharmacology , Adenine/therapeutic use , Animals , Antiviral Agents/therapeutic use , Cell Line , Drug Resistance, Microbial , Female , Guanine , Herpesviridae Infections/pathology , Herpesvirus 1, Equid/genetics , Lung/pathology , Mice , Mice, Inbred BALB C , Mutation , Organophosphorus Compounds/pharmacology , Organophosphorus Compounds/therapeutic use , Rabbits , Thymidine Kinase/metabolism
10.
Arch Virol ; 123(3-4): 351-66, 1992.
Article in English | MEDLINE | ID: mdl-1314051

ABSTRACT

Six specific pathogen-free foals shown to be free of equine herpesvirus-1 and 4 (EHV-1 and -4) and lacking in maternally-derived antibodies were used to investigate the pathogenesis of EHV-1 in horses. Following primary intranasal inoculation with EHV-1 all foals showed signs of a mild, self-limiting upper respiratory tract infection. A leucopenia was observed, comprising both a lymphopenia and neutropenia. Virus was isolated from nasal mucus and buffy coat cells over several days during the clinical episode and after the animals became clinically normal. Notwithstanding the mildness of the clinical disease, virus was not eliminated completely and intravenous administration of dexamethasone resulted in reactivation of latent EHV-1 in animals which had received only a single dose of the virus. In a second infection given to four foals, 61 days after the primary inoculation, no clinical signs were observed, haematological changes were minimal and viraemia was absent.


Subject(s)
Herpesviridae Infections/veterinary , Herpesvirus 1, Equid/physiology , Horse Diseases/microbiology , Animals , Body Temperature , Culture Techniques/veterinary , Dexamethasone/pharmacology , Female , Fluorescent Antibody Technique , Hematologic Tests/veterinary , Herpesviridae Infections/immunology , Herpesviridae Infections/physiopathology , Herpesvirus 1, Equid/growth & development , Herpesvirus 1, Equid/isolation & purification , Horses , Immunity, Active , Male , Neutralization Tests , Specific Pathogen-Free Organisms , Virus Activation , Virus Replication
11.
Arch Virol ; 123(3-4): 409-19, 1992.
Article in English | MEDLINE | ID: mdl-1314054

ABSTRACT

Balb/c mice were inoculated with equine herpesvirus-1 (EHV-1) by the intranasal (i.n.) route. Mice developed respiratory signs; virus replication occurred in the respiratory tract and viraemia was detected; some mice died. Recovered mice were given a second inoculation with the same strain 5 months later. Following the second infection no mice died, however, virus replication was again observed in the respiratory tract and viraemia was detected once more. Administration of an antiviral agent during the acute infection prevented mice from developing severe clinical signs and all survived. These mice, and some that had survived an acute infection without chemotherapy, were given a variety of stimuli, for example X-irradiation or corticosteroid injection. Reappearance of infectious virus was detected in approx. 1/3 animals in either the respiratory tract or blood. We speculate on the possible sites of latency in the model.


Subject(s)
Herpesviridae Infections/veterinary , Herpesvirus 1, Equid/physiology , Virus Activation , Animals , Cells, Cultured , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Herpesviridae Infections/microbiology , Herpesviridae Infections/pathology , Herpesvirus 1, Equid/growth & development , Lung/pathology , Mice , Mice, Inbred BALB C , Virus Replication
12.
Res Vet Sci ; 51(1): 94-9, 1991 Jul.
Article in English | MEDLINE | ID: mdl-1654586

ABSTRACT

Balb/c mice were infected with two abortigenic strains of equine herpesvirus-1 (EHV-1) by intranasal inoculation. The inoculation of one strain produced subclinical disease while the other produced a disease characterised by weight loss, constitutional signs, and death in the most severely affected animals. When pregnant mice were infected by the same method of inoculation, one strain of virus produced premature parturition; both strains produced fetal abnormalities. In some cases, virus could be detected in the aborted fetuses by means of virus isolation and immunofluorescent staining.


Subject(s)
Abortion, Veterinary/microbiology , Disease Models, Animal , Herpesviridae Infections/veterinary , Herpesvirus 1, Equid/physiology , Horse Diseases/microbiology , Abortion, Veterinary/pathology , Animals , Animals, Newborn/microbiology , Female , Fetus/microbiology , Herpesviridae Infections/microbiology , Herpesviridae Infections/pathology , Herpesvirus 1, Equid/isolation & purification , Horse Diseases/pathology , Horses , Lung/pathology , Mice , Mice, Inbred BALB C , Placenta/microbiology , Pregnancy , Viremia/microbiology , Viremia/veterinary
13.
Antiviral Res ; 16(1): 29-39, 1991 Jul.
Article in English | MEDLINE | ID: mdl-1663728

ABSTRACT

The compound (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine (HPMPA) had been previously shown to be highly effective in treatment of EHV-1 in a murine model for the equine disease. This paper describes the isolation of a series of mutants resistant to the drug. Resistance was demonstrated in cell culture and one mutant was tested in a murine model. The resistant mutant was pathogenic for mice; infectious virus was recovered from respiratory tissues and blood at levels similar to the parental virus. However, the mutant showed a significant degree of resistance in vivo, thus proving the virus-specific mode of action of the antiviral compound.


Subject(s)
Adenine/analogs & derivatives , Antiviral Agents/pharmacology , Herpesviridae Infections/microbiology , Herpesvirus 1, Equid/drug effects , Organophosphonates , Organophosphorus Compounds/pharmacology , Adenine/pharmacology , Adenine/therapeutic use , Animals , Antiviral Agents/therapeutic use , Cell Line , Drug Resistance, Microbial , Female , Herpesviridae Infections/drug therapy , Herpesvirus 1, Equid/genetics , Herpesvirus 1, Equid/isolation & purification , Mice , Mice, Inbred BALB C , Mutation , Organophosphorus Compounds/therapeutic use , Phenotype
14.
Equine Vet J ; 23(2): 111-5, 1991 Mar.
Article in English | MEDLINE | ID: mdl-1646103

ABSTRACT

Over a period of two years, a total of 22 full term foals from Welsh Mountain pony mares were raised in conditions that were free from infection by Equid herpesvirus (EHV-1/4). Parturition dates were predicted by monitoring colostrum electrolytes, and the mares allowed to foal naturally under supervision or following induction with intravenous oxytocin. Immediately following birth, foals were separated from their dams and transferred to a specially built, positive pressure isolation unit. They were given antibiotic prophylaxis and fed bovine colostrum during the first 24 h, and then mare's milk replacer until weaned. Out of 22 specific pathogen free (SPF) foals one that had not been given antibiotic prophylaxis died of an E. coli septicaemia aged eight days. Two foals developed a streptococcal upper respiratory tract infection, which responded to antibiotic therapy and did not spread to the rest of the herd. A self limiting upper respiratory tract infection was seen in a fourth foal and mild diarrhoea was observed in six foals. Physical development in all SPF foals appeared normal and behavioural patterns resembled those of conventional handreared foals. Newborn foals were held in a separate quarantine area, within the isolation unit, and checked extensively for evidence of EHV-1/4 infection, before being transferred to the main holding unit. Periodic checks were then made for EHV-1/4 over a period ranging from 2 to 4 months; none of the SPF foals showed evidence of infection with EHV-1/4 in terms of clinical disease, virus isolation, sero-conversion or specific lymphocyte transformation.


Subject(s)
Animals, Newborn/immunology , Colostrum/immunology , Horses/immunology , Immunity, Maternally-Acquired , Specific Pathogen-Free Organisms/immunology , Animals , Anti-Bacterial Agents/therapeutic use , Antibodies, Viral/blood , Cattle , Colostrum/chemistry , Electrolytes/analysis , Female , Herpesviridae/immunology , Herpesviridae Infections/immunology , Herpesviridae Infections/veterinary , Herpesvirus 1, Equid/immunology , Horse Diseases/immunology , Pregnancy
15.
J Gen Virol ; 71 ( Pt 5): 1131-40, 1990 May.
Article in English | MEDLINE | ID: mdl-2161048

ABSTRACT

An infection was established in adult BALB/c mice by means of intranasal inoculation of the AB4 strain of equine herpesvirus type 1 (EHV-1). The acute infection was confined to the respiratory tract and blood. Virus was shown to replicate in the nasal mucosa, trachea and lung for several days producing clinical signs of disease. Viraemia was also detected and a small proportion of peripheral blood cells contained virus at the peak of the infection. Histological and electron microscopic evidence were obtained which proved that productive virus replication occurred in the ciliated epithelial cells lining the bronchi and in pneumocytes in the lung, resulting in the destruction of these cells. Both humoral and cell-mediated responses to the infection were detected and monitored. By means of immunoprophylaxis or chemotherapy it was possible to modify the course of the infection. This infection model has many striking features in common with that observed in the natural host and the observations suggest that the mouse is a convenient and relevant model in which to study both host responses to EHV-1 infection and modification of the pathogenesis by means of immunoprophylaxis or therapy.


Subject(s)
Disease Models, Animal , Herpesviridae Infections , Herpesviridae/physiology , Herpesvirus 1, Equid/physiology , Animals , Antibodies, Viral/biosynthesis , Cell Line , Herpesviridae Infections/immunology , Herpesviridae Infections/microbiology , Herpesviridae Infections/pathology , Herpesvirus 1, Equid/immunology , Herpesvirus 1, Equid/isolation & purification , Immunization , Immunization, Passive , Lung/microbiology , Lung/ultrastructure , Mice , Mice, Inbred BALB C , Mice, Inbred Strains , Microscopy, Electron , Viremia , Virus Replication
16.
Antimicrob Agents Chemother ; 34(5): 709-17, 1990 May.
Article in English | MEDLINE | ID: mdl-2163242

ABSTRACT

Equine herpesvirus 1 was established in adult mice by means of intranasal inoculation. A disease developed that showed several features closely resembling the infection in the natural host. These included the restriction of virus replication to the respiratory tract and blood, the replication of virus in ciliated mucosa, and development of viremia for several days during the acute phase of the infection. Infected mice were treated with the antiviral agent (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine. A marked effect was observed on virus replication in the respiratory tract when chemotherapy was commenced 1 day before virus inoculation; it also cleared the viremia and reversed the progression of clinical signs. When chemotherapy was commenced 1 day after virus inoculation, a moderate, though less marked effect was observed. The efficacy of this drug in the murine infection correlated with activity of the drug against equine herpesvirus 1 in cell cultures. The prospects for chemotherapy in the natural host are discussed in the light of these findings.


Subject(s)
Adenine/analogs & derivatives , Antiviral Agents/therapeutic use , Herpesviridae Infections/drug therapy , Organophosphonates , Adenine/therapeutic use , Animals , Culture Techniques , Drug Resistance, Microbial , Herpesviridae Infections/microbiology , Herpesvirus 1, Equid/drug effects , Herpesvirus 1, Equid/physiology , Mice , Mice, Inbred BALB C , Organophosphorus Compounds/therapeutic use , Viral Plaque Assay , Virus Replication/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...